A field and laboratory study in eastern Nepal found neem oil gave the strongest suppression of the leaf-eating caterpillar ...

A brine shrimp lethality assay found that aqueous and methanol extracts of three Ethiopian medicinal plants traditionally ...

How many years India’s biotech curriculum trails its factories. Eight technologies, the delay on each, who is quietly paying ...

The US FDA has approved a new potency assay Mesoblast will use to release commercial batches of its approved cell therapy. The shares have nonetheless slipped over the past month, extending a soft ...

Mesoblast (AU000000MSB8) stock last traded at USD 14.08 on Nasdaq on October 2, 2026 at 4:00 p.m. ET, down 1.68 percent from the prior session. The move leaves the biotechnology company 34.5 percent ...

Researchers at the Indian Institute of Technology Guwahati have developed a compact, low-energy wastewater treatment system ...

Uncover the latest and most impactful research in Glycoside. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the field. Withania somnifera (L.) Dunal, ...

Mesoblast gained FDA approval for a new potency assay to release commercial Ryoncil batches. What it means for scaling up.

The authors describe a method-validation-by-design (MVbD) approach to validate a method over a range of formulations using both design-of-experiment and quality-by-design principles to define a design ...

Boost ROI through local distribution, stronger service, research partnerships, and AI-enabled diagnostics as chronic disease needs and digital health adoption riseDublin, Oct. 02, 2026 (GLOBE NEWSWIRE ...